Clinical Picture, Outcome, and Risk of Serious Bacterial Infections in Immunocompetent Previously Healthy Neutropenic Children

Abstract

Objective In childhood, the cause of neutropenia is a challenging diagnosis with a spectrum of underlying etiologies. This study was performed to investigate the clinical picture and the outcomes associated with the new onset neutropenia in previously healthy children, and to determine the risk of serious bacterial infection (SBI) in those patients.

Methods Patients presenting between January 2018 and September 2018 with an absolute neutrophil count (ANC) <1,500/μL were retrospectively evaluated. Patients with known underlying chronic disease or immunosuppressive conditions were excluded. Neutropenia was categorized into three groups: mild, 1,000–1,500/μL; moderate, 500 to <1,000/μL; and severe <500/μL.

Results A total of 423 patients were investigated. There were 156 (36.9%), 193 (45.6%), and 74 (17.5%) patients in the mild, moderate, and severe groups, respectively. Bacteremia was detected in one (0.02%) patient and SBI in 21 (4.9%) patients. No significant correlation was found between the incidence of SBI and bacterial infection rate among different age groups (p > 0.05). The incidence of SBI varied significantly according to the severity of the neutropenia (p = 0.012) and as the neutropenia became more severe, the incidence of SBI increased (p = 0.015).

Conclusion The clinical outcome of neutropenia in previously healthy and immunocompetent children is generally good with a relatively low incidence of SBI. We suggest that aggressive therapy and frequent follow-up should be reserved for previously healthy neutropenic children with SBI.

Keywords

serious bacterial infection - neutropenia - immunocompetent - child

Publikationsverlauf

Eingereicht: 16. Mai 2020

Angenommen: 22. Februar 2021

Artikel online veröffentlicht:
21. Mai 2021

• References

• 1 Bonilla MA, Menell JS. Chapter 13 - Disorders of White Blood Cells. In: Lanzkowsky P, Lipton JM, Fish JD. eds. Lanzkowsky's Manual of Pediatric Hematology and Oncology (Sixth Edition). Academic Press; 2016: 209-238
• 2 Walkovich K, Boxer LA. How to approach neutropenia in childhood. Pediatr Rev 2013; 34 (04) 173-184
• 3 Celkan T, Koç BŞ. Approach to the patient with neutropenia in childhood. Turk Pediatri Ars 2015; 50 (03) 136-144
• 4 Alexandropoulou O, Kossiva L, Haliotis F. et al. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up. Eur J Pediatr 2013; 172 (06) 811-819
• 5 Lubran MM. Hematologic side effects of drugs. Ann Clin Lab Sci 1989; 19 (02) 114-121
• 6 David O, Fruchtman Y, Sergienko R, Kapelushnik J, Leibovitz E. The infectious and noninfectious etiology, clinical picture and outcome of neutropenia in immunocompetent hospitalized children. Pediatr Infect Dis J 2018; 37 (06) 570-575
• 7 Barg AA, Kozer E, Mordish Y, Lazarovitch T, Kventsel I, Goldman M. The risk of serious bacterial infection in neutropenic immunocompetent febrile children. J Pediatr Hematol Oncol 2015; 37 (06) e347-e351
• 8 Alario AJ, O'Shea JS. Risk of infectious complications in well-appearing children with transient neutropenia. Am J Dis Child 1989; 143 (08) 973-976
• 9 Husain EH, Mullah-Ali A, Al-Sharidah S, Azab AF, Adekile A. Infectious etiologies of transient neutropenia in previously healthy children. Pediatr Infect Dis J 2012; 31 (06) 575-577
• 10 Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia. Acad Emerg Med 2010; 17 (02) 163-167
• 11 Rautiainen L, Pavare J, Grope I, Tretjakovs P, Gardovska D. Inflammatory cytokine and chemokine patterns in paediatric patients with suspected serious bacterial infection. Medicina 2019; 55 (01) 4
• 12 Pascual C, Trenchs V, Hernández-Bou S, Català A, Valls AF, Luaces C. Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department. Eur J Clin Microbiol Infect Dis 2016; 35 (10) 1667-1672
• 13 Serwint JR, Dias MM, Chang H, Sharkey M, Walker AR. Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting. Clin Pediatr (Phila) 2005; 44 (07) 593-600
• 14 Pérez-Méndez C, Molinos-Norniella C, Morán-Poladura M, Fernandez-Rodríguez E, Suarez-Castanon C, Solís-Sanchez G. Low risk of bacteremia in otherwise healthy children presenting with fever and severe neutropenia. Pediatr Infect Dis J 2010; 29 (07) 671-672
• 15 Vlacha V, Feketea G. The clinical significance of non-malignant neutropenia in hospitalized children. Ann Hematol 2007; 86 (12) 865-870
• 16 Bonadio WA, Smith DS, Mathews S, Rock A. Clinical significance of newly documented neutropenia in febrile young infants evaluated for sepsis. Pediatr Infect Dis J 1991; 10 (05) 407-408
• 17 Hu L, Shi Q, Shi M, Liu R, Wang C. Diagnostic value of PCT and CRP for detecting serious bacterial infections in patients with fever of unknown origin: a systematic review and meta-analysis. Appl Immunohistochem Mol Morphol 2017; 25 (08) e61-e69
• 18 Paydar-Darian N, Kimia AA, Monuteaux MC. et al. C-reactive protein or erythrocyte sedimentation rate results reliably exclude invasive bacterial infections. Am J Emerg Med 2019; 37 (08) 1510-1515